BBP Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Nov 10 at 4:00 PM ET (Korea 11/11 06:00)AI-drawn chart patterns are for reference only.
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.34% | Return% 1Y | 40.88% | Total Holdings | 68 | Perf Week | 0.22% | Volume | 14,913 |
| Asset Type | Equities (Stocks) | AUM | $136M | Return% 3Y | 29.94% | NAV | $104.38 | Perf Month | 0.12% | Avg Volume | 0.01M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | 14.45% | 52W High | -5.72% | Perf Quarter | 1.8% | Rel Volume | 1.19 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | 13.59% | 52W Low | 40.26% | Perf Half Y | 17.39% | Prev Close | $104.53 |
| IPO | 2014/12/17 | Flows% 1M | 3.99% | Return% SI | 12.52% | RSI (14) | 50.36 | Perf YTD | 29.83% | Price | $103.75 |
| Beta | 0.58 | Flows% 3M | 23.86% | Flows% YTD | 109.71% | Flows% 1Y | 156.51% | Perf Year | 38.31% | Volatility(W/M) | 2.98% 2.41% |
| SMA20 | 0.2% | SMA50 | -0.35% | SMA200 | 11.31% | ATR | 2.57 | ||||
Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
The top 10 make up 20% of the fund
Spread evenly across many holdings.
CRNX CRINETICS PHARMACEUTICALS INC 3.34% 2 
KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC 1.97% 3 
VSTM VERASTEM INC 1.95% 4 
PGEN PRECIGEN INC 1.94% 5 
OMER OMEROS CORP 1.87% 6 
NUVB NUVATION BIO INC 1.77% 7 
REGN REGENERON PHARMACEUTICALS 1.72% 8 
PTGX PROTAGONIST THERAPEUTICS INC 1.71% 9 
ACAD ACADIA PHARMACEUTICALS INC 1.69% 10 
ONC BEONE MEDICINES LTD 1.65% Largest sectors first.
Over the past 1 year, on the higher side
6% below its 1-year high.
Traded about as much as usual. That is 119% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +104.0%. The S&P 500 did +62% over the same period.
Tap to view numbers
The price swings a lot
At its worst (February 2021) it fell 44% and took 659 days to recover.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Money keeps flowing in
Over the past year, new money equal to 156.5% of assets came in.
Tap to view numbers
CURE Direxion Daily Healthcare Bull 3X ETF 211M 
RXL ProShares Ultra Health Care 2X Shares 117M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 40M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 4M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
XLV State Street Health Care Select Sector SPDR ETF 0.08% 
VHT Vanguard Health Care ETF 0.09% 
XBI State Street SPDR S&P Biotech ETF 0.35% 
IYH iShares U.S. Healthcare ETF 0.37% 
IHI iShares U.S. Medical Devices ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
